Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-499
Closed -$14K 904
2016
Q4
$14K Buy
499
+82
+20% +$2.3K ﹤0.01% 451
2016
Q3
$11K Hold
417
﹤0.01% 485
2016
Q2
$9K Hold
417
﹤0.01% 471
2016
Q1
$9K Buy
417
+112
+37% +$2.42K ﹤0.01% 553
2015
Q4
$6K Sell
305
-228
-43% -$4.49K ﹤0.01% 594
2015
Q3
$13K Buy
+533
New +$13K ﹤0.01% 441
2015
Q2
Sell
-305
Closed -$8K 958
2015
Q1
$8K Buy
+305
New +$8K ﹤0.01% 582

Other funds holding QGENF

Zions Bancorporation's QGENF Position: Q1 2017 in Review

Zions Bancorporation sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 499 shares — an estimated $14K sold.

Zions Bancorporation first reported a position in QGENF in Q1 2015 and held it in 7 quarters. The position peaked at $14K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Zions Bancorporation reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Zions Bancorporation sold 499 QIAGEN NV shares in Q1 2017, an estimated $14K.
  • Zions Bancorporation first reported a position in QIAGEN NV in Q1 2015 and held it in 7 quarters.
  • Zions Bancorporation's QIAGEN NV position peaked at $14K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Zions Bancorporation's 13F filing for Q1 2017, filed 15 May 2017.